Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
955.8 INR | +0.47% | +3.75% | +38.81% |
Apr. 24 | Zydus Lifesciences Gets 10 Observations from US FDA After Jarod, India Manufacturing Site Inspection | MT |
Apr. 23 | China Medical System's Anti-Anaemia NDA Accepted in China | MT |
Evolution of the average Target Price on Zydus Lifesciences Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Zydus Lifesciences Limited
Jefferies & Co. | |
Nomura |
EPS Revisions
- Stock Market
- Equities
- ZYDUSLIFE Stock
- Consensus Zydus Lifesciences Limited